A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants with Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519015-34-00

Acronym

D9961C00001

Enrollment

Registered

2025-06-18

Start date

2025-06-30

Completion date

Unknown

Last updated

2025-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Inflammatory Myopathies, Systemic Lupus Erythematosus

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026